Abstract: The present invention provides a method of treating frontotemporal dementia, or a childhood genetic neurodegenerative disease such as Ataxia Telangiectasia (A-T), or neurodegenerative diseases such as Parkinson's disease or neuropsychiatric diseases comprising administering to a subject in need thereof an effective amount of chlorite composition, such as sodium chlorite. The present invention thereby provides a method of modulating the immune system in a subject in need thereof. Described herein are methods of administration and treatment.
Type:
Grant
Filed:
January 10, 2023
Date of Patent:
March 26, 2024
Assignees:
NEUVIVO, INC., THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Abstract: The present invention provides a method of treating frontotemporal dementia, or a childhood genetic neurodegenerative disease such as Ataxia Telangiectasia (A-T), or neurodegenerative diseases such as Parkinson's disease or neuropsychiatric diseases comprising administering to a subject in need thereof an effective amount of chlorite composition, such as sodium chlorite. The present invention thereby provides a method of modulating the immune system in a subject in need thereof. Described herein are methods of administration and treatment.
Type:
Grant
Filed:
January 10, 2023
Date of Patent:
March 26, 2024
Assignees:
NEUVIVO, INC., THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Abstract: The present invention provides a method of treating frontotemporal dementia, or a childhood genetic neurodegenerative disease such as Ataxia Telangiectasia (A-T), or neurodegenerative diseases such as Parkinson's disease or neuropsychiatric diseases comprising administering to a subject in need thereof an effective amount of chlorite composition, such as sodium chlorite. The present invention thereby provides a method of modulating the immune system in a subject in need thereof. Described herein are methods of administration and treatment.
Type:
Grant
Filed:
August 30, 2022
Date of Patent:
March 26, 2024
Assignees:
NEUVIVO, INC., THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Abstract: The present invention provides a method of treating frontotemporal dementia, or a childhood genetic neurodegenerative disease such as Ataxia Telangiectasia (A-T), or neurodegenerative diseases such as Parkinson's disease or neuropsychiatric diseases comprising administering to a subject in need thereof an effective amount of chlorite composition, such as sodium chlorite. The present invention thereby provides a method of modulating the immune system in a subject in need thereof. Described herein are methods of administration and treatment.
Type:
Grant
Filed:
January 10, 2023
Date of Patent:
March 26, 2024
Assignees:
NEUVIVO, INC., THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
© 2024 Justia
